NCBI PubMed Centralopen access
Physiologically based pharmacokinetic model of two ALK inhibitors to inform drug and dosing regimens for brain metastasis patients.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 455407
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.